Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KB | Q9UBF8 | 9/20 | 0.44 |
| ▸ | SMPD3 | Q9NY59 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20533695 | 0.96 | PI4KB (0.42) | PI4KBSMPD3LMNASMN1; SMN2MAPT | |
| SCHEMBL20533914 | 0.92 | PI4KB (0.42) | PI4KBSMPD3LMNASMN1; SMN2MAPT | |
| SCHEMBL20533660 | 0.89 | PI4KB (0.35) | PI4KBLMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL20533887 | 0.86 | PI4KB (0.47) | PI4KBSMPD3LMNASMN1; SMN2MAPT | |
| SCHEMBL20533930 | 0.86 | SMN1; SMN2 (0.39) | LMNASMN1; SMN2ALDH1A1TSHRKDM4E | |
| SCHEMBL20533904 | 0.83 | PI4KB (0.60) | PI4KBLMNASMN1; SMN2MAPTMEN1 | |
| SCHEMBL20533899 | 0.78 | PI4KB (0.61) | PI4KBLMNASMN1; SMN2MAPTMEN1 | |
| SCHEMBL20533924 | 0.77 | PI4KB (0.45) | PI4KBSMPD3LMNASMN1; SMN2MAPT | |
| SCHEMBL20533595 | 0.76 | PI4KB (0.61) | PI4KBSMPD3SMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL20533575 | 0.76 | SMN1; SMN2 (0.42) | LMNASMN1; SMN2MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180298009-A1 | Fused Pyrazole Derivatives As Kinase Inhibitors | UCB BIOPHARMA SPRL (BE) | 2018-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180298009-A1 | Fused Pyrazole Derivatives As Kinase Inhibitors | PI4KA, PI4K2B, PI4KB | PI4KB 3/4885SMPD3 2463/4885LMNA 4839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.